Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations.

The British journal of dermatology - 1 Jan 2014

Hüffmeier U, Wätzold M, Mohr J, Schön M P, Mössner R

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dermatologic Agents
Share to Interleukin 1 Receptor Antagonist Protein
Share to Interleukins
Share to Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Psoriasis

Share to Treatment Outcome

Source

Identifiers

PMID: 23909475
DOI: 10.1111/bjd.12548

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations.PMID 23909475Read ↗

Successful treatment of generalized pustular psoriasis with the interleukin-1-receptor antagonist Anakinra: lack of correlation with IL1RN mutations.Semantic proximity Read ↗

IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasisSemantic proximity Read ↗

Erythema multiforme after initiating spesolimab in a patient with generalized pustular psoriasis with IL36RN mutation.Semantic proximity Read ↗

Generalized pustular psoriasis-like drug eruption manifested by systemic glucocorticosteroid in a patient without IL36RN mutation or an immunological disorder.Semantic proximity Read ↗

Generalized Pustular Psoriasis With IL-36 Receptor Antagonist Mutation Successfully Treated With Granulocyte and Monocyte Adsorption Apheresis Accompanied by Reduced Serum IL-6 Level.Semantic proximity Read ↗

Mutations in IL36RN in Patients with Generalized Pustular PsoriasisSemantic proximity Read ↗

Novel IL36RN Mutation Identified in Pediatric-Onset Generalized Pustular Psoriasis Causes IL36 Antagonist DegradationSemantic proximity Read ↗

Annular pustular psoriasis with a heterozygous IL36RN mutation.Semantic proximity Read ↗

Clinical profile of patients with acute generalized pustular psoriasis with and without IL36RN mutations in multi-ethnic Johor Bahru, Malaysia.Semantic proximity Read ↗

Therapeutic Efficacy of Interleukin 12/Interleukin 23 Blockade in Generalized Pustular Psoriasis Regardless of IL36RN Mutation Status.Semantic proximity Read ↗

Interleukin-36 receptor antagonist deficiency patient with a novel mutation.Semantic proximity Read ↗

Generalized pustular psoriasis: immunological mechanisms, genetics, and emerging therapeutics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.